Markets Stifel ups Tabula Rasa HealthCare to buy; PT to $75 from $70 Stifel upgraded Tabula Rasa HealthCare (NASDAQ:TRHC) to “buy” from “hold” and raised its price target to $75 from $70, citing an “improving risk/reward with a favorable fundamental backdrop.” The stock closed at $57.64... August 30, 2019